Compare Ionis Pharmaceuticals Inc. Common Stock (IONS) vs Occidental Petroleum Corporation (OXY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ionis Pharmaceuticals Inc. Common Stock vs Occidental Petroleum Corporation — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $42.5 (market cap $7.04B), while Occidental Petroleum Corporation trades at $61.45 (market cap $61.63B). The key difference: Occidental Petroleum Corporation is far larger — about 8.8× Ionis Pharmaceuticals Inc. Common Stock's market cap, and Occidental Petroleum Corporation pays a 1.82% dividend while Ionis Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and Occidental Petroleum Corporation for 92 Days on average.
| IONS | OXY | |
|---|---|---|
Market Cap | $7.04B | $61.63B |
Volume | 2,977,440 | 9,180,422 |
Sector | Health | Energy |
52-Week High | $86.50 | $66.24 |
52-Week Low | $42.38 | $38.92 |
Typical Hold Time | 0 Days | 92 Days |
Enterprise Value | $6.60B | $80.39B |
Dividend Yield | — | 1.82% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Occidental Petroleum (OXY) trades at $61.41, up 0.46% with strong technical momentum and bullish moving average signals. The company demonstrates robust profitability with 30.32% net income margin and 21.46% ROE, though revenue has declined from $36.6B in 2022 to $21.6B in 2025. Recent earnings beats and a $71.40 consensus price target suggest upside potential, supported by Goldman Sachs' October 1 upgrade citing cash flow targets and debt reduction plans.
OXY presents a compelling value opportunity with attractive valuation multiples (P/E 18.19, EV/EBITDA 5.66) and strong analyst support (52% buy rating). Key risks include oil price volatility and declining revenue trends, while catalysts include upcoming Q3 earnings and continued operational efficiency improvements. The stock's technical strength and fundamental value create favorable risk-reward dynamics for energy sector exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →About Occidental Petroleum Corporation
Occidental Petroleum is an independent exploration and production company with operations in the United States, Latin America, and the Middle East. At the end of 2021, the company reported net proved reserves of 3.5 billion barrels of oil equivalent. Net production averaged 1,174 thousand barrels of oil equivalent per day in 2021 at a ratio of 75% oil and natural gas liquids and 25% natural gas.
Read more on OXY →
